Author(s): Nepom GT
Abstract Share this page
Abstract The role for HLA typing in autoimmune disease is changing with the recognition that HLA markers can identify patients with poor prognosis in some autoimmune disease. Aggressive therapeutic intervention in patients with such HLA prognostic markers has the potential to improve or prevent progressive disease outcomes in a select group of patients.
This article was published in Annu Rev Med
and referenced in Cloning & Transgenesis